Wagner, S., Wuerdemann, N., Huebbers, C., Reuschenbach, M., Prigge, E. -S., Wichmann, G., Hess, J., Dietz, A., Duerst, M., Tinhofer, I., von Knebel-Doeberitz, M., Wittekindt, C. and Klussmann, J. P. (2015). HPV-associated head and neck cancer. Mutational signature and genomic aberrations. HNO, 63 (11). S. 758 - 768. NEW YORK: SPRINGER. ISSN 1433-0458

Full text not available from this repository.

Abstract

A significantly increasing proportion of oropharyngeal head and neck carcinomas (OSCC) in North America and Europe are associated with human papillomavirus (HPV) infections. HPV-related OSCC is regarded as a distinct tumor type with regard to its cellular, biologic, and clinical characteristics. Patients with HPV-related OSCC have significantly better local control, but higher rates of regional lymph node and distant metastases as compared to patients with HPV-negative OSCC. Classical molecular genetic investigations demonstrated specific chromosomal aberration signatures in HPV-related OSCC, and recent developments in next generation sequencing (NGS) technology have rendered possible the sequencing of entire genomes, and thus detection of specific mutations, in just a few days. Initial data from The Cancer Genome Atlas (TCGA) project obtained by using genome-wide high throughput methods have confirmed that HPV-related OSCC contain fewer, albeit more specific mutations than HPV-negative tumors. Additionally, these data revealed the presence of specific-potentially therapeutically targetable-activating driver mutations in subgroups of HPV-positive OSCC, some of which have a prognostic impact. Specific targeted NGS technologies provide new possibilities for identification of diagnostic, prognostic, and predictive biomarkers and the development of personalized cancer treatment. Patients with HPV-positive tumors are likely to profit from these developments in the future, since the genetic alterations are relatively homogenous and frequently lead to signal pathway activation. There is an urgent need for network research activities to carry out the necessary basic research in prospective cohort studies.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Wagner, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wuerdemann, N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Huebbers, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reuschenbach, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Prigge, E. -S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wichmann, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hess, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dietz, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Duerst, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tinhofer, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Knebel-Doeberitz, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wittekindt, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Klussmann, J. P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-387814
DOI: 10.1007/s00106-015-0074-x
Journal or Publication Title: HNO
Volume: 63
Number: 11
Page Range: S. 758 - 768
Date: 2015
Publisher: SPRINGER
Place of Publication: NEW YORK
ISSN: 1433-0458
Language: German
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
SQUAMOUS-CELL CARCINOMA; GENETIC PROGRESSION MODEL; HUMAN-PAPILLOMAVIRUS; EXPRESSION; P16; INTEGRATION; DYSPLASIA; INFECTION; INDICATOR; DNAMultiple languages
OtorhinolaryngologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/38781

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item